HDAC9 and atherosclerosis: Accumulating evidence has highlighted the detrimental roles of HDAC9 in atherosclerosis [35], liver fibrosis [36], autoimmune disease [37], cancer [38], and Alzheimer’s disease [39] in both humans and mice.